Literature DB >> 30368019

Where, when, and how many tuberculosis patients are lost from presumption until treatment initiation? A step by step assessment in a rural district in Zimbabwe.

Admire S Murongazvombo1, Riitta A Dlodlo2, Hemant Deepak Shewade3, Valerie Robertson4, Susumu Hirao5, Elijah Pikira6, Cedric Zhanero7, Rachael K Taruvinga8, Precious Andifasi9, Cremence Tshuma10.   

Abstract

OBJECTIVES: To describe the pre-diagnosis and pre-treatment loss to follow-up (LTFU) in the tuberculosis (TB) care cascade in Guruve (2015-16), a rural district in Zimbabwe.
DESIGN: Guruve has 19 rural health centres (RHCs) and one district hospital. In this cohort study, persons ≥15 years of age with presumptive pulmonary TB were tracked from the facility presumptive TB registers to the laboratory registers; if laboratory diagnosed, they were tracked to the district TB register (contains details of all TB patients registered for treatment). Each patient was tracked for 90days after registration as presumptive TB and for 90days after laboratory diagnosis. Environmental health technicians transported sputum specimens from the health facilities to the laboratories (n=3).
RESULTS: Of 2974 persons with presumptive TB, pre-diagnosis LTFU occurred in 575 (19%, 95% confidence interval 18-21%). Associated factors included registration at a RHC, at a facility more than 2km from the laboratory, and absence of an environmental health technician. Of 162 laboratory diagnosed pulmonary TB patients, pre-treatment LTFU occurred in 19 (12%, 95% confidence interval 8-18%).
CONCLUSIONS: The presumptive TB register was helpful to assess the pre-diagnosis gaps beginning from presumption. Pre-diagnosis LTFU can be reduced by placement of an environmental health technician at all facilities.
Copyright © 2018 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Diagnosis and treatment cascade; Early diagnosis; Operational research; Pre-diagnosis loss to follow-up; Pre-treatment loss to follow-up; SORT IT; Tuberculosis/diagnosis; Tuberculosis/treatment

Mesh:

Year:  2018        PMID: 30368019     DOI: 10.1016/j.ijid.2018.10.013

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  10 in total

1.  The role of bacteriological monitoring using culture and drug susceptibility tests (CDST) on treatment outcomes among MDR/RR-TB patients on treatment: a cohort analysis of patients enrolled on treatment 2010-2015 in Zimbabwe.

Authors:  Ronnie Matambo; Shungu Mutero-Munyati; Vongai Mildred Pepuka; Tendai Nkomo; Charles Sandy; Mkhokheli Ngwenya; Gilchriste Ndongwe; Elliot Chikaka; Sungano Mharakurwa; George Nyandoro
Journal:  Pan Afr Med J       Date:  2021-06-02

2.  Eliminating tuberculosis by 2035: tackling the financial barriers at all stages of the cascade of care.

Authors:  C Timire; C Sandy; A D Harries
Journal:  Int J Tuberc Lung Dis       Date:  2019-11-01       Impact factor: 2.373

3.  The Growing Importance of Tuberculosis Preventive Therapy and How Research and Innovation Can Enhance Its Implementation on the Ground.

Authors:  Anthony D Harries; Ajay M V Kumar; Srinath Satyanarayana; Pruthu Thekkur; Yan Lin; Riitta A Dlodlo; Mohammed Khogali; Rony Zachariah
Journal:  Trop Med Infect Dis       Date:  2020-04-16

4.  Evaluation of Xpert MTB-RIF guided diagnosis and treatment of rifampicin-resistant tuberculosis in Indonesia: A retrospective cohort study.

Authors:  Arto Yuwono Soeroto; Bony Wiem Lestari; Prayudi Santoso; Lidya Chaidir; Basti Andriyoko; Bachti Alisjahbana; Reinout van Crevel; Philip C Hill
Journal:  PLoS One       Date:  2019-02-28       Impact factor: 3.240

5.  Losses in the Sputum Specimen Referral Cascade in Mpulungu District, Zambia: A Cross-Sectional Study.

Authors:  Ruth Goma; Josphat Bwembya; Brian Mwansa; Phillimon Ndubani; Francis Kasongo; William Siame; Lutinala Mulenga; Ramya Kumar; Seraphine Kaminsa; Vimbai Makwambeni; Victoria Musonda; Ibou Thior; Alwyn Mwinga
Journal:  Int J Environ Res Public Health       Date:  2022-01-31       Impact factor: 3.390

6.  Mobile targeted screening for tuberculosis in Zimbabwe: diagnosis, linkage to care and treatment outcomes.

Authors:  T Sengai; C Timire; A D Harries; H Tweya; F Kavenga; G Shumba; J Tavengerwei; R Ncube; C Zishiri; M J Mapfurira; V Mandizvidza; C Sandy
Journal:  Public Health Action       Date:  2019-12-21

7.  Where are patients missed in the tuberculosis diagnostic cascade? A prospective cohort study in Ghana.

Authors:  Joyce B Der; Daniel Grint; Clement T Narh; Frank Bonsu; Alison D Grant
Journal:  PLoS One       Date:  2020-03-19       Impact factor: 3.240

8.  Evaluating the integration of tuberculosis screening and contact investigation in tuberculosis clinics in Ethiopia: A mixed method study.

Authors:  L Ketema; Z G Dememew; D Assefa; T Gudina; A Kassa; T Letta; B Ayele; Y Tadesse; B Tegegn; D G Datiko; C Negeri; A Bedru; E Klinkenberg
Journal:  PLoS One       Date:  2020-11-19       Impact factor: 3.240

9.  Magnitude and Reasons for Gaps in Tuberculosis Diagnostic Testing and Treatment Initiation: An Operational Research Study from Dakshina Kannada, South India.

Authors:  Imaad Mohammed Ismail; Akshaya Kibballi Madhukeshwar; Poonam Ramesh Naik; Badarudeen Mohammad Nayarmoole; Srinath Satyanarayana
Journal:  J Epidemiol Glob Health       Date:  2020-05-23

10.  Universal Access to Xpert MTB/RIF Testing for Diagnosis of Tuberculosis in Uzbekistan: How Well Are We Doing?

Authors:  Laziz Turaev; Ajay Kumar; Dilyara Nabirova; Sevak Alaverdyan; Nargiza Parpieva; Barno Abdusamatova
Journal:  Int J Environ Res Public Health       Date:  2021-03-12       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.